LILRA5/CD85f/ILT11, His & Avi, Human
LILRA5/CD85f/ILT11, His & Avi, Human

The purity of LILRA5/CD85f/ILT11, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

LILRA5/CD85f/ILT11, His & Avi, Human

LILRA5/CD85f/ILT11, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

LILRA5/CD85f/ILT11, His & Avi, Human

The leukocyte immunoglobulin-like receptors (LILR) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIRs). Human LILRA5, also known as ILT11, LIR-9, and CD85f, consists of a 227 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane segment, and a 10 aa cytoplasmic tail. LILRA5 may play a role in triggering innate immune responses. Does not seem to play a role for any class I MHC antigen recognition.
Z05588
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
LILRA5/CD85f/ILT11 (Gly42-Arg268)_x000D_
Accession # A6NI73-1		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 28.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 38-50 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • LILRA5/CD85f/ILT11, His & Avi, Human
    • LILRA5/CD85f/ILT11, His & Avi, Human

    The purity of LILRA5/CD85f/ILT11, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • LILRA5/CD85f/ILT11, His & Avi, Human
    • LILRA5/CD85f/ILT11, His & Avi, Human

    LILRA5/CD85f/ILT11, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The leukocyte immunoglobulin-like receptors (LILR) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIRs). Human LILRA5, also known as ILT11, LIR-9, and CD85f, consists of a 227 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane segment, and a 10 aa cytoplasmic tail. LILRA5 may play a role in triggering innate immune responses. Does not seem to play a role for any class I MHC antigen recognition.
Synonyms CD85; CD85f; ILT11; ILT-11; ILT11CD85f; LILRA5; LILRB7; LIR9; LIR-9

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.